Publikationen, an denen er mitarbeitet Begoña Castro (19)

2020

  1. H2O2-preconditioned human adipose-derived stem cells (HC016) increase their resistance to oxidative stress by overexpressing Nrf2 and bioenergetic adaptation

    Stem Cell Research and Therapy, Vol. 11, Núm. 1

  2. Hydrogen peroxide-preconditioned human adipose-derived stem cells enhance the recovery of oligodendrocyte-like cells after oxidative stress-induced damage

    International Journal of Molecular Sciences, Vol. 21, Núm. 24, pp. 1-14

2019

  1. Cryopreserved H 2 O 2 -preconditioned human adipose-derived stem cells exhibit fast post-thaw recovery and enhanced bioactivity against oxidative stress

    Journal of Tissue Engineering and Regenerative Medicine, Vol. 13, Núm. 2, pp. 328-341

2017

  1. HR007: a family of biomaterials based on glycosaminoglycans for tissue repair

    Journal of Tissue Engineering and Regenerative Medicine, Vol. 11, Núm. 4, pp. 989-1001

2016

  1. Generation of tunable glycosaminoglycan hydrogels to mimic extracellular matrices

    Journal of Tissue Engineering and Regenerative Medicine, Vol. 10, Núm. 12, pp. 1000-1011

2015

  1. Development and preclinical evaluation of a new galactomannan-based dressing with antioxidant properties for wound healing

    Histology and Histopathology, Vol. 30, Núm. 12, pp. 1499-1512

2011

  1. Crystallinity assessment and in vitro cytotoxicity of polylactide scaffolds for biomedical applications

    Journal of Materials Science: Materials in Medicine, Vol. 22, Núm. 11, pp. 2513-2523

2006

  1. Cytomodulation of interleukin-2 effect by L-2-oxothiazolidine-4-carboxylate on human malignant melanoma

    Cancer Immunology, Immunotherapy, Vol. 55, Núm. 8, pp. 948-957

  2. Influence of the level of γ-glutamyltranspeptidase activity on the response of poorly and moderately differentiated rhabdomyosarcoma cell lines to all-trans-retinoic acid

    Anti-Cancer Drugs, Vol. 17, Núm. 10, pp. 1127-1139

2002

  1. L-2-oxothiazolidine-4-carboxylate reverses the tumour growth-promoting effect of interleukin-2 and improves the anti-tumour efficacy of biochemotherapy in mice bearing B16 melanoma liver metastases

    Melanoma Research, Vol. 12, Núm. 1, pp. 17-26

  2. Role of γ-glutamyltranspeptidase on the response of poorly and moderately differentiated rhabdomyosarcoma cell lines to buthionine sulfoximine-induced inhibition of glutathione synthesis

    Anti-Cancer Drugs, Vol. 13, Núm. 3, pp. 281-291

2000

  1. Effects of L-2-oxothiazolidine-4-carboxylate on the cytotoxic activity and toxicity of cyclophosphamide in mice bearing B16F10 melanoma liver metastases

    Melanoma Research, Vol. 10, Núm. 2, pp. 103-112

  2. Removal of N-glycans from cell surface proteins induces apoptosis by reducing intracellular glutathione levels in the rhabdomyosarcoma cell line S4MH

    Biology of the Cell, Vol. 92, Núm. 8-9, pp. 639-646

  3. Tunicamycin treatment reduces intracellular glutathione levels: Effect on the metastatic potential of the rhabdomyosarcoma cell line S4MH

    Chemotherapy, Vol. 46, Núm. 6, pp. 408-428

1999

  1. In vitro and in vivo comparison between the effects of treatment with adenosine triphosphate and treatment with buthionine sulfoximine on chemosensitization and tumour growth of B16 melanoma

    Melanoma Research, Vol. 9, Núm. 3, pp. 233-242

1997

  1. Interleukin-2 increases intracellular glutathione levels and reverses the growth inhibiting effects of cyclophosphamide on B16 melanoma cells

    Clinical and Experimental Metastasis, Vol. 15, Núm. 3, pp. 329-337

1996

  1. HOX genes and cell adhesion molecules in cancers.

    The International journal of developmental biology, Vol. Suppl 1

  2. Tumor-host interaction in non-random metastatic pattern distribution

    Bulletin du Cancer, Vol. 83, Núm. 1, pp. 27-38

1995

  1. A simple cell labeling technique by means of lectins linked to fluorochromes for the detection of cells on tissue sections

    Biology of the Cell, Vol. 83, Núm. 1, pp. 87-92